|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Howell LP, Zhou H, Wu W and Davis R:
Significance of subclassifying high-grade squamous intraepithelial
lesions into moderate dysplasia/CIN II versus severe dysplasia/CIN
III/CIS in the bethesda system terminology. Diagn Cytopathol.
30:362–366. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeng K, Zheng W, Mo X, Liu F, Li M, Liu Z,
Zhang W and Hu X: Dysregulated microRNAs involved in the
progression of cervical neoplasm. Arch Gynecol Obstet. 292:905–913.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wardak S: Human Papillomavirus (HPV) and
cervical cancer. Med Dosw Mikrobiol. 68:73–84. 2016.PubMed/NCBI
|
|
5
|
Syrjänen KJ and Syrjänen SM: Human
papillomavirus (HPV) typing as an adjunct to cervical cancer
screening. Cytopathology. 10:8–15. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wen Y, Pan XF, Zhao ZM, Chen F, Fu CJ, Li
SQ, Zhao Y, Chang H, Xue QP and Yang CX: Knowledge of human
papillomavirus (HPV) infection, cervical cancer, and HPV vaccine
and its correlates among medical students in Southwest China: A
multi-center cross-sectional survey. Asian Pac J Cancer Prev.
15:5773–5779. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hildesheim A and Wang SS: Host and viral
genetics and risk of cervical cancer: A review. Virus Res.
89:229–240. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martin CM, Astbury K and O'Leary JJ:
Molecular profiling of cervical neoplasia. Expert Rev Mol Diagn.
6:217–229. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bertelsen BI, Steine SJ, Sandvei R, Molven
A and Laerum OD: Molecular analysis of the PI3K-AKT pathway in
uterine cervical neoplasia: Frequent PIK3CA amplification and AKT
phosphorylation. Int J Cancer. 118:1877–1883. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheung TH, Lo KW, Yim SF, Chan LK, Heung
MS, Chan CS, Cheung AY, Chung TK and Wong YF: Epigenetic and
genetic alternation of PTEN in cervical neoplasm. Gynecol Oncol.
93:621–627. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang PH, Yang SF, Chen GD, Han CP, Chen
SC, Lin LY and Ko JL: Human nonmetastatic clone 23 type 1 gene
suppresses migration of cervical cancer cells and enhances the
migration inhibition of fungal immunomodulatory protein from
Ganoderma tsugae. Reprod Sci. 14:475–485. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pareja R, Rendón GJ, Sanz-Lomana CM,
Monzón O and Ramirez PT: Surgical, oncological, and obstetrical
outcomes after abdominal radical trachelectomy-a systematic
literature review. Gynecol Oncol. 131:77–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kogo R, How C, Chaudary N, Bruce J, Shi W,
Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin
axis regulates migration, invasion and lymph node metastasis in
cervical cancer. Oncotarget. 6:1090–1100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sevignani C, Calin GA, Siracusa LD and
Croce CM: Mammalian microRNAs: A small world for fine-tuning gene
expression. Mamm Genome. 17:189–202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang B, Wang Q and Pan X: MicroRNAs and
their regulatory roles in animals and plants. J Cell Physiol.
210:279–289. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fei B and Wu H: MiR-378 inhibits
progression of human gastric cancer MGC-803 cells by targeting
MAPK1 in vitro. Oncol Res. 20:557–564. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Yin B, Wang B, Ma Z, Liu W and Lv
G: MicroRNA-210 promotes proliferation and invasion of peripheral
nerve sheath tumor cells targeting EFNA3. Oncol Res. 21:145–154.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang WH, Gui JH, Wang CZ, Chang Q, Xu SP,
Cai CH, Li YN, Tian YP, Yan L and Wu B: The identification of
miR-375 as a potential biomarker in distal gastric adenocarcinoma.
Oncol Res. 20:139–147. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Misawa A, Katayama R, Koike S, Tomida A,
Watanabe T and Fujita N: AP-1-Dependent miR-21 expression
contributes to chemoresistance in cancer stem cell-like SP cells.
Oncol Res. 19:23–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ohdaira H, Sekiguchi M, Miyata K and
Yoshida K: MicroRNA-494 suppresses cell proliferation and induces
senescence in A549 lung cancer cells. Cell Prolif. 45:32–38. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cho WC, Chow AS and Au JS: Restoration of
tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung
adenocarcinoma patients with epidermal growth factor receptor
mutation. Eur J Cancer. 45:2197–2206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu T, Tang H, Lang Y, Liu M and Li X:
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by
targeting prohibitin. Cancer Lett. 273:233–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu D, Zhou Y, Pan H, Zhou J, Fan Y and Qu
P: microRNA-99a inhibiting cell proliferation, migration and
invasion by targeting fibroblast growth factor receptor 3 in
bladder cancer. Oncol Lett. 7:1219–1224. 2014.PubMed/NCBI
|
|
24
|
Li E, Zhang J, Yuan T and Ma B: MiR-145
inhibits osteosarcoma cells proliferation and invasion by targeting
ROCK1. Tumour Biol. 35:7645–7650. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gururajan M, Josson S, Chu GC, Lu CL, Lu
YT, Haga CL, Zhau HE, Liu C, Lichterman J, Duan P, et al: miR-154*
and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate
epithelial to mesenchymal transition and bone metastasis of
prostate cancer. Clin Cancer Res. 20:6559–6569. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Ma X, Cai Q, Wang X, Yu B, Cai Q,
liu B, Zhu Z and Li C: MiR-199a-3p promotes gastric cancer
progression by targeting ZHX1. FEBS Lett. 588:4504–4512. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu T, Hou L and Huang Y: EZH2-specific
microRNA-98 inhibits human ovarian cancer stem cell proliferation
via regulating the pRb-E2F pathway. Tumour Biol. 35:7239–7247.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qiu F, Sun R, Deng N, Guo T, Cao Y, Yu Y,
Wang X, Zou B, Zhang S, Jing T, et al: miR-29a/b enhances cell
migration and invasion in nasopharyngeal carcinoma progression by
regulating SPARC and COL3A1 gene expression. PLoS One.
10:e01209692015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alizadeh S, Kaviani S, Soleimani M, Abroun
S, Kashani-Khatib Z, Asgharzadeh A, Dargahi H and Mousavi R: Mir-55
inhibition can reduce cell proliferation and induce apoptosis in
Jurkat (Acute T cell Leukemia) cell line. Iran J Ped Hematol Oncol.
4:141–150. 2014.PubMed/NCBI
|
|
30
|
Saldanha G, Elshaw S, Sachs P, Alharbi H,
Shah P, Jothi A and Pringle JH: microRNA-10b is a prognostic
biomarker for melanoma. Mod Pathol. 29:112–121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang YY, Li L, Ye ZY, Zhao ZS and Yan ZL:
MicroRNA-10b promotes migration and invasion through Hoxd10 in
human gastric cancer. World J Surg Oncol. 13:2592015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang J, Sun C, Wang S, He Q and Li D:
microRNA miR-10b inhibition reduces cell proliferation and promotes
apoptosis in non-small cell lung cancer (NSCLC) cells. Mol Biosyst.
11:2051–2059. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ji Y, Wei Y, Wang J, Gong K, Zhang Y and
Zuo H: Correlation of microRNA-10b upregulation and poor prognosis
in human gliomas. Tumour Biol. 36:6249–6254. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang YF, Li Z, Zhao XH, Zuo XM, Zhang Y,
Xiao YH, Li J and Peng ZH: MicroRNA-10b is upregulated and has an
invasive role in colorectal cancer through enhanced Rhoc
expression. Oncol Rep. 33:1275–1283. 2015.PubMed/NCBI
|
|
35
|
Xiao H, Li H, Yu G, Xiao W, Hu J, Tang K,
Zeng J, He W, Zeng G, Ye Z and Xu H: MicroRNA-10b promotes
migration and invasion through KLF4 and HOXD10 in human bladder
cancer. Oncol Rep. 31:1832–1838. 2014.PubMed/NCBI
|
|
36
|
Han X, Yan S, Weijie Z, Feng W, Liuxing W,
Mengquan L and Qingxia F: Critical role of miR-10b in transforming
growth factor-β1-induced epithelial-mesenchymal transition in
breast cancer. Cancer Gene Ther. 21:60–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun XJ, Liu H, Zhang P, Zhang XD, Jiang ZW
and Jiang CC: miR-10b promotes migration and invasion in
nasopharyngeal carcinoma cells. Asian Pac J Cancer Prev.
14:5533–5537. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ouyang H, Gore J, Deitz S and Korc M:
microRNA-10b enhances pancreatic cancer cell invasion by
suppressing TIP30 expression and promoting EGF and TGF-β actions.
Oncogene. 33:4664–4674. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liao CG, Kong LM, Zhou P, Yang XL, Huang
JG, Zhang HL and Lu N: miR-10b is overexpressed in hepatocellular
carcinoma and promotes cell proliferation, migration and invasion
through RhoC, uPAR and MMPs. J Transl Med. 12:2342014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang YY, Ye ZY, Zhao ZS, Li L, Wang YX,
Tao HQ, Wang HJ and He XJ: Clinicopathologic significance of
miR-10b expression in gastric carcinoma. Hum Pathol. 44:1278–1285.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang J, Xu L, Yang Z, Lu H, Hu D, Li W,
Zhang Z, Liu B and Ma S: MicroRNA-10b indicates a poor prognosis of
non-small cell lung cancer and targets E-cadherin. Clin Transl
Oncol. 17:209–214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nishida N, Yamashita S, Mimori K, Sudo T,
Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y and Mori M:
MicroRNA-10b is a prognostic indicator in colorectal cancer and
confers resistance to the chemotherapeutic agent 5-fluorouracil in
colorectal cancer cells. Ann Surg Oncol. 19:3065–3071. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li QJ, Zhou L, Yang F, Wang GX, Zheng H,
Wang DS, He Y and Dou KF: MicroRNA-10b promotes migration and
invasion through CADM1 in human hepatocellular carcinoma cells.
Tumour Biol. 33:1455–1465. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu Y, Li M, Zhang G and Pang Z:
MicroRNA-10b overexpression promotes non-small cell lung cancer
cell proliferation and invasion. Eur J Med Res. 18:412013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
He C, Zhao X, Jiang H, Zhong Z and Xu R:
Demethylation of miR-10b plays a suppressive role in ccRCC cells.
Int J Clin Exp Pathol. 8:10595–10604. 2015.PubMed/NCBI
|
|
46
|
Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM,
Li Y, Nelson RA, Mu B, Onami SH, et al: Identification of a
4-microRNA signature for clear cell renal cell carcinoma metastasis
and prognosis. PLoS One. 7:e356612012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yu Z, Ni L, Chen D, Zhang Q, Su Z, Wang Y,
Yu W, Wu X, Ye J, Yang S, et al: Identification of miR-7 as an
oncogene in renal cell carcinoma. J Mol Histol. 44:669–677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Steller MA, Delgado CH, Bartels CJ,
Woodworth CD and Zou Z: Overexpression of the insulin-like growth
factor-1 receptor and autocrine stimulation in human cervical
cancer cells. Cancer Res. 56:1761–1765. 1996.PubMed/NCBI
|
